Citadel Advisors
BGMD

Citadel Advisors’s BG MEDICINE INC COM STK NEW BGMD Stock Holding History

Citadel Advisors’s Portfolio BGMD Stock Details BGMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-8,274
Closed -$18K – 9593
2015
Q2 		$18K Buy
+8,274
New +$23.5K ﹤0.01% 8222
2015
Q1 		– Sell
-10,158
Closed -$19K – 9168
2014
Q4 		$19K Buy
10,158
+987
+11% +$1.65K ﹤0.01% 7875
2014
Q3 		$20K Buy
+9,171
New +$30.7K ﹤0.01% 7453
2014
Q2 		– Sell
-11,397
Closed -$88K – 8652
2014
Q1 		$88K Buy
+11,397
New +$63K ﹤0.01% 6322
2013
Q3 		– Sell
-4,871
Closed -$26K – 7031
2013
Q2 		$26K Buy
+4,871
New +$32.5K ﹤0.01% 5963

Other funds holding BGMD

AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

Citadel Advisors's BGMD Position: Q3 2015 in Review

Citadel Advisors sold out of BG MEDICINE INC COM STK NEW (BGMD) in Q3 2015, closing a stake of 8,274 shares — an estimated $18K sold.

Citadel Advisors first reported a position in BGMD in Q2 2013 and held it in 5 quarters. The position peaked at $88K in Q1 2014. 2 funds tracked by Wall St. Rank hold BGMD as of Q3 2015.

  • Citadel Advisors reported no remaining BG MEDICINE INC COM STK NEW position as of Q3 2015 after selling out during the quarter.
  • Citadel Advisors sold 8,274 BG MEDICINE INC COM STK NEW shares in Q3 2015, an estimated $18K.
  • Citadel Advisors first reported a position in BG MEDICINE INC COM STK NEW in Q2 2013 and held it in 5 quarters.
  • Citadel Advisors's BG MEDICINE INC COM STK NEW position peaked at $88K in Q1 2014.
  • 2 funds tracked by Wall St. Rank held BG MEDICINE INC COM STK NEW as of Q3 2015.

Based on Citadel Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.